Sabra Healthcare Reit Stock Price on May 15, 2024

SBRA Stock  USD 17.02  0.08  0.47%   
Below is the normalized historical share price chart for Sabra Healthcare REIT extending back to November 08, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sabra Healthcare stands at 17.02, as last reported on the 28th of December, with the highest price reaching 17.09 and the lowest price hitting 16.86 during the day.
IPO Date
2nd of April 2002
200 Day MA
16.3458
50 Day MA
18.357
Beta
1.235
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Sabra Stock, it is important to understand the factors that can impact its price. Sabra Healthcare REIT owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0659, which indicates the firm had a -0.0659% return per unit of risk over the last 3 months. Sabra Healthcare REIT exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sabra Healthcare's Variance of 2.4, risk adjusted performance of (0.05), and Coefficient Of Variation of (1,406) to confirm the risk estimate we provide.
  
At present, Sabra Healthcare's Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Capital Stock is expected to grow to about 2.4 M, whereas Total Stockholder Equity is forecasted to decline to about 2.1 B. . At present, Sabra Healthcare's Price To Sales Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price Earnings Ratio is expected to grow to 251.83, whereas Price Earnings To Growth Ratio is projected to grow to (1.94). Sabra Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0659

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSBRA

Estimated Market Risk

 1.56
  actual daily
13
87% of assets are more volatile

Expected Return

 -0.1
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Sabra Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sabra Healthcare by adding Sabra Healthcare to a well-diversified portfolio.
Price Book
1.4739
Enterprise Value Ebitda
16.895
Price Sales
5.8937
Shares Float
233.2 M
Dividend Share
1.2

Sabra Healthcare Valuation on May 15, 2024

It is possible to determine the worth of Sabra Healthcare on a given historical date. On May 15, 2024 Sabra was worth 14.04 at the beginning of the trading date compared to the closed value of 13.72. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sabra Healthcare stock. Still, in general, we apply an absolute valuation method to find Sabra Healthcare's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sabra Healthcare where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sabra Healthcare's related companies.
 Open High Low Close Volume
  13.78    13.92    13.71    13.89    1,707,020  
05/15/2024
  14.04    14.10    13.65    13.72    2,732,636  
  13.72    13.78    13.57    13.69    2,026,659  
Backtest Sabra Healthcare  |  Sabra Healthcare History  |  Sabra Healthcare Valuation   PreviousNext  
Open Value
14.04
13.72
Closing Value
18.73
Upside

Sabra Healthcare Trading Date Momentum on May 15, 2024

On May 16 2024 Sabra Healthcare REIT was traded for  13.69  at the closing time. The top price for the day was 13.78  and the lowest listed price was  13.57 . The trading volume for the day was 2 M. The trading history from May 16, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.22% . The trading price change against the current closing price is 1.82% .

Sabra Healthcare REIT Fundamentals Correlations and Trends

By evaluating Sabra Healthcare's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sabra Healthcare's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sabra financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Sabra Healthcare Stock history

Sabra Healthcare investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sabra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sabra Healthcare REIT will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sabra Healthcare stock prices may prove useful in developing a viable investing in Sabra Healthcare
Last ReportedProjected for Next Year
Common Stock Shares Outstanding232.8 M131.1 M
Net Loss-69.8 M-66.4 M

Sabra Healthcare Quarterly Net Working Capital

449.64 Million

Sabra Healthcare Stock Technical Analysis

Sabra Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Sabra Healthcare technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Sabra Healthcare trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Sabra Healthcare Period Price Range

Low
December 28, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Sabra Healthcare REIT cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Sabra Healthcare December 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Sabra Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sabra Healthcare shares will generate the highest return on investment. By undertsting and applying Sabra Healthcare stock market strength indicators, traders can identify Sabra Healthcare REIT entry and exit signals to maximize returns

Sabra Healthcare Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Sabra Healthcare's price direction in advance. Along with the technical and fundamental analysis of Sabra Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sabra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Sabra Stock analysis

When running Sabra Healthcare's price analysis, check to measure Sabra Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Healthcare is operating at the current time. Most of Sabra Healthcare's value examination focuses on studying past and present price action to predict the probability of Sabra Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Healthcare's price. Additionally, you may evaluate how the addition of Sabra Healthcare to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios